You are here

  • Home
  • Online First
  • Comorbidities in a Mexican mestizo cohort with established rheumatoid arthritis

Article Text

Article menu

other Versions

Download PDFPDF
Letter
Comorbidities in a Mexican mestizo cohort with established rheumatoid arthritis
  1. David Vega-Morales,
  2. Marta Barrón-Almazán,
  3. Ana Arana-Guajardo
  1. Hospital General de Zona No. 17, Instituto Mexicano del Seguro Social, Fortunato Lozano, Benito
  1. Correspondence to Dr David Vega-Morales. Hospital General de Zona No. 17, Instituto Mexicano del Seguro Social, Fortunato Lozano 2627 Benito Juárez, C.P. 64218 Monterrey, México; drdavidvega{at}yahoo.com.mx

https://doi.org/10.1136/annrheumdis-2013-204895

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In the study recently published in the Annals of Rheumatic Diseases, Dougados et al1 evaluated the prevalence of comorbidities and compared their management in rheumatoid arthritis (RA) patients from different countries. We know that RA is a chronic autoimmune disease characterised by chronic inflammation, progressive deterioration of joint function, increased comorbidity and mortality; RA patients have about a 50% increased risk of premature mortality.2 A comorbid condition may represent an active, past or transient illness and may be linked to RA process itself and/or its treatment or it may be completely independent of them3; the average RA patient has approximately 1.6 comorbidities.4 We conducted an observational, cross-sectional, non-comparative study to describe the presence of comorbidities in RA Mexican mestizo …

    View Full Text

    Footnotes

    • Contributors DV-M: designed data collection tools, monitored data collection for the whole study, wrote the statistical analysis plan, cleaned and analysed the data and drafted and revised the paper. MB-A: monitored data collection for the whole trial, analysed the data and drafted and revised the paper. AA-G: analysed the data and drafted and revised the paper.

    • Competing interests None.

    • Ethics approval Hospital General de Zona No. 17, Instituto Mexicano del Seguro Social with number: R-2013-1906-35.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles